{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:29:08Z","timestamp":1748579348295,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12253-016-0135-9","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T23:38:37Z","timestamp":1476833917000},"page":"487-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calret\u0131n\u0131n"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-1164","authenticated-orcid":false,"given":"Nurhan","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Nur","family":"Akatli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet Reha","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakk\u0131","family":"Ulutas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine Turkmen","family":"Samdanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemil","family":"Colak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"135_CR1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","volume":"178","author":"F Gueugnon","year":"2011","unstructured":"Gueugnon F, Leclercq S, Blanquart C et al (2011) Identification of novel markers for the diagnosis of malignant pleural mesothelioma. Am J Pathol 178:1033\u20131042","journal-title":"Am J Pathol"},{"key":"135_CR2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","volume":"41","author":"V Panel","year":"2015","unstructured":"Panel V, Vyberg M, Weinreich UM et al (2015) The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev 41:486\u2013495","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"135_CR3","first-page":"52","volume":"51","author":"V Ascoli","year":"2015","unstructured":"Ascoli V (2015) Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines. Ann Ist Super Sanita 51(1):52\u201359","journal-title":"Ann Ist Super Sanita"},{"key":"135_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5146\/tjpath.2013.01158","volume":"29","author":"O Ucer","year":"2013","unstructured":"Ucer O, Dagli AF, K\u0131l\u0131carslan A et al (2013) Value of glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma, and pulmonary adenocarcinoma. Turkish J Pathol 29:94\u2013100","journal-title":"Turkish J Pathol"},{"key":"135_CR5","unstructured":"Travis WD, Brambilla E, M\u00fcller-Hermelink HK, Harris CC (eds) (2004) World Health Organization classification of Tumours. Pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC Press: Lyonn"},{"key":"135_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1309\/AJCPM2Z4NGIIPBGE","volume":"140","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Hiroshima K, Suzuki T et al (2013) CD 90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry. Am J Clin Pathol 140:544\u2013549","journal-title":"Am J Clin Pathol"},{"key":"135_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2009.03322.x","volume":"55","author":"VJ Amatya","year":"2009","unstructured":"Amatya VJ, Takeshima Y, Kohno H et al (2009) Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma. Histopathology 55:10\u201319","journal-title":"Histopathology"},{"key":"135_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2009.03326.x","volume":"55","author":"P Cassoni","year":"2009","unstructured":"Cassoni P, Daniele L, Maldi E et al (2009) Caveolin-1 expression in lung carcinoma varies according to tumor histotype and is acquired de novo in brain metastases. Histopathology 55:20\u201327","journal-title":"Histopathology"},{"key":"135_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lungcan.2011.07.009","volume":"75","author":"A Zieglee","year":"2012","unstructured":"Zieglee A, Cerciello F, Bigosch C et al (2012) Proteomic surface some analysis of mesothelioma. Lung Cancer 75:189\u2013196","journal-title":"Lung Cancer"},{"key":"135_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.prp.2014.02.011","volume":"210","author":"G Yilmaz","year":"2014","unstructured":"Yilmaz G, Akyol G, Cakir A et al (2014) Investigation of diagnostic utility and expression profiles of stem cell markers (CD 133 and CD 90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis. Pathol Res Pract 210:419\u2013425","journal-title":"Pathol Res Pract"},{"key":"135_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2010.03.004","volume":"20","author":"PC Hermann","year":"2010","unstructured":"Hermann PC, Bhaskar S, Cioffi M et al (2010) Cancer stem cells in solid tumors. Semin Cancer Biol 20:77\u201384","journal-title":"Semin Cancer Biol"},{"key":"135_CR12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.seminoncol.2012.05.011","volume":"39","author":"J Ji","year":"2012","unstructured":"Ji J (2012) Wang Xw. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol 39:461\u2013472","journal-title":"Semin Oncol"},{"key":"135_CR13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.prp.2009.06.001","volume":"205","author":"H Deniz","year":"2009","unstructured":"Deniz H, Kibar Y, Guldur ME et al (2009) Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations? Pathol Res Pract 205:749\u2013752","journal-title":"Pathol Res Pract"},{"key":"135_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anndiagpath.2015.03.007","volume":"19","author":"S Chaouche-Mazouni","year":"2015","unstructured":"Chaouche-Mazouni S, Scherpereel A, Zaamoum R et al (2015) Claudin 3, 4, and 15 expressions in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma. Ann Diagn Pathol 19:193\u2013197","journal-title":"Ann Diagn Pathol"},{"key":"135_CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/modpathol.3800534","volume":"19","author":"H Yaziji","year":"2006","unstructured":"Yaziji H, Battifora H, Barry TS et al (2006) Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 19:514\u2013523","journal-title":"Mod Pathol"},{"key":"135_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","volume":"19","author":"NG Ordonez","year":"2006","unstructured":"Ordonez NG (2006) The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesothelioma and squamous carcinoma of the lung: a comparative study. Mod Pathol 19:417\u2013428","journal-title":"Mod Pathol"},{"key":"135_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2008.01.013","volume":"13","author":"ZF Yang","year":"2008","unstructured":"Yang ZF, Ho DW, Ng MN et al (2008) Significance of CD 90+ cancer stem cells in human liver cancer. Cancer Cell 13:153\u2013166","journal-title":"Cancer Cell"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-016-0135-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-016-0135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T02:30:44Z","timestamp":1496111444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-016-0135-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1007\/s12253-016-0135-9","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"type":"print","value":"1219-4956"},{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2016,10,19]]}}}